EIF4A3 helps cells handle messenger RNA, the working copy of genetic instructions used to make proteins. This gene plays an important role in guiding early growth, especially as tissues form before birth. If the EIF4A3 gene does not work properly, protein-making signals can become less coordinated, which may lead to developmental differences such as changes in the face, jaw, and limbs seen in Richieri-Costa-Pereira syndrome. EIF4A3 is mainly known in medical genetics rather than in popular culture.
What is a gene?
Genes are stretches of DNA that provide cells with instructions they can use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the working parts of cells. Others mainly help determine when, where, and how strongly certain processes take place. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
EIF4A3Gene function
What if the gene works
The EIF4A3 gene helps cells handle messenger RNA, the working copy of genetic instructions. Its protein is part of a group that checks RNA processing and supports normal protein production and development.
Risk
What if the gene does not work
When the EIF4A3 gene works poorly, it is best known for causing Richieri-Costa-Pereira syndrome, which affects facial development, the mouth and jaw, and the hands. Milder and more severe variants can change when features appear and how pronounced they are.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the EIF4A3 gene do not currently have an established treatment or drug selection approach that is specific to this gene in clinical guidelines. The EIF4A3 gene is being studied as a possible drug target and biomarker in some cancers, but this work is still early and does not yet guide routine care.
Conditions associated with EIF4A3
Gene function
What if the gene works
Your cells use the EIF4A3 gene to manage RNA, the working copy of genetic instructions used to make proteins. It helps label newly processed messages so they can be checked, moved, and used in an orderly way. Understanding how the EIF4A3 gene works helps explain how cells keep protein production organized.
The EIF4A3 gene helps place a marker on messenger RNA after sections have been cut and rejoined. This shows the cell that the message has passed through a key processing step.
Its protein stays with some RNA messages as they leave the nucleus and move to the part of the cell where proteins are made. This helps each message reach the right stage at the right time.
The EIF4A3 gene helps cells review RNA messages before too much protein is made from them. It supports a cleanup system that removes messages carrying an early stop signal.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EIF4A3 gene often cut the amount of protein a cell can make, especially when extra repeated DNA in a control region turns the gene down. Other changes can alter the EIF4A3 protein's shape and weaken how it binds RNA and partner proteins. This range helps explain why some EIF4A3 gene variants affect RNA processing more mildly, while more severe variants are linked to earlier or more marked features of Richieri-Costa-Pereira syndrome.
How variants are linked to conditions
Pathogenic variants in the EIF4A3 gene cause Richieri-Costa-Pereira syndrome, a rare inherited condition affecting facial and limb development. In the well-established EIF4A3 gene and Richieri-Costa-Pereira syndrome link, people may have a small lower jaw, cleft palate, feeding or breathing difficulties early in life, and differences in finger or toe development. Finding disease-causing variants in both copies of the EIF4A3 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead represent part of natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks related to the EIF4A3 gene. Risk is mainly shaped by the specific gene change inherited in a family, so people with concerns about their personal or family risk should speak with a doctor or genetic counselor.
Inheritance of EIF4A3 variants
EIF4A3-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one EIF4A3 gene variant from each parent, and parents who carry one variant typically do not have the condition themselves. When both parents carry an EIF4A3 gene variant, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. This is the usual explanation of how EIF4A3 gene variants are inherited in affected families.
What does my EIF4A3 result mean for my family?
For families with an EIF4A3-related condition, the pattern is autosomal recessive, which means parents are often healthy carriers. Brothers and sisters may also be affected or may be carriers, and other relatives on both sides of the family could carry the changed gene too. This can matter for future pregnancies and for relatives who are planning children.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the EIF4A3 gene uses a blood sample, saliva sample, or cheek swab. An EIF4A3 genetic test reads the DNA sequence to look for changes and compares them with known patterns. Results may identify a variant or show no clinically relevant change.
When should I consider getting a genetic test?
Consider EIF4A3 testing when a child has the pattern of birth differences seen in Richieri-Costa-Pereira syndrome, such as cleft palate, a small lower jaw, and hand or foot differences, or when this condition runs in the family. It can also help clarify whether parents are carriers after having an affected child.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and on the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in someone else. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the EIF4A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or response, so questions about side effects, medication changes, or other health concerns are best discussed with your doctor.